1 / 1

ZOLADEX(Goserelin)

Acetylcysteine Injection, FLUIMUCIL, Acetylcysteine InjectionAcetylcysteine Injection, FLUIMUCIL, Acetylcysteine InjectionAcetylcysteine Injection, FLUIMUCIL, Acetylcysteine Injection

Reference price:

Manufacturer:

TerSera Therapeutics

Formulation:

IMPLANT

Validity period:

Reminder: The outer packaging is for reference only, please purchase and use under the guidance of a pharmacist. For read by medical and pharmaceutical professionals only.

ZOLADEX(Goserelin) Instructions:Uses,Dosage, Side Effects

Goserelin Acetate Implant (ZOLADEX®) is a sustained-release GnRH agonist used to suppress testosterone in prostate cancer. Administered subcutaneously every 12 weeks, it induces medical castration, slowing tumor progression.

Key indications include locally advanced (Stage B2-C) and metastatic prostate cancer, often combined with radiation or flutamide. Risks include tumor flare, cardiovascular events, and injection site injury. Monitoring testosterone levels and managing hyperglycemia are critical during therapy.

Generic name

ZOLADEX(Goserelin)

English name

Goserelin

Alternative Names

ZOLADEX

Drug prices

Indications

Locally Confined Prostate Cancer (Stage B2–C): Used in combination with flutamide and radiotherapy. Initiated 8 weeks prior to radiation and continued during therapy.

Advanced Prostate Cancer: Palliative treatment for metastatic diseas.

Therapeutic Target

Gonadotropin-Releasing Hormone (GnRH) receptors in the pituitary gland. Suppresses luteinizing hormone (LH) and follicle-stimulating hormone (FSH), leading to testosterone reduction to castration levels.

Active Ingredients

Goserelin acetate

Dosage form

IMPLANT

specifications

3.6mg*1vial/box

Description

Chemical Structure: Synthetic decapeptide GnRH analog ([D-Ser(Bu⁶),Azgly¹⁰]).

Matrix: Biodegradable D,L-lactic and glycolic acids copolymer (36.0 mg total implant weight).

Release Profile: Sustained release over 12 weeks.

Dosage and Administration

1. Dose: 10.8 mg administered subcutaneously every 12 weeks.

2. Site: Anterior abdominal wall below the navel line.

3. Technique:

3.1 Aseptic technique; avoid muscle/peritoneum penetration.

3.2 Insert needle at 30–45° angle; no aspiration required.

3.3 Monitor for vascular injury (risk in low BMI or anticoagulated patients).

4. Missed Dose: Adhere to 12-week schedule; brief delays permissible.

CATEGORY NAVIGATION

RECOMMENDED ARTICLES

Key Considerations for Goserelin

Goserelin (Zoladex) has brought good news to patients who need to treat diseases such as prostate cancer,...

Wednesday, July 23rd, 2025, 16:59

Goserelin treatment of breast cancer patients

Goserelin sustained-release injection is suitable for prostate cancer, uterine leiomyoma, and breast cancer....

Wednesday, July 23rd, 2025, 16:41

Precautions for Goserelin

Goserelin is a hormone modulator commonly used to treat hormone-dependent diseases such as breast cancer,...

Wednesday, July 23rd, 2025, 16:18

Dosage and Administration of Goserelin

As a hormone regulator, Goserelin mainly inhibits the secretion of gonadotropin-releasing hormone (GnRH). By...

Wednesday, July 23rd, 2025, 16:00

How many versions of Goserelin (zoladex) are there? How to buy it?

Goserelin is a hormone regulator, commonly used to treat a variety of hormone-dependent diseases, including...

Wednesday, July 23rd, 2025, 15:37

Is Goserelin (zoladex) expensive? How much does a box cost?

Goserelin is a synthetic analog of luteinizing hormone-releasing hormone (LHRH), mainly used to treat...

Wednesday, July 23rd, 2025, 15:06

Departments

Oncology Hematology Immunology Hepatology Endocrinology Pulmonology Neurology Cardiology Gastroenterology Dermatology

Contact Medical Consultant

Global Drug Search

Clinical recruitment

overseas medical treatment

Remote consultation

Note: Our medical consultant will contact you as soon as possible. We promise to strictly protect your privacy.

Click to submit medical consultant

Mailbox:Info@Lucius.La

Welcome To Consult